Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News $
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2013's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
More on PCYC
- Summary
- Chart
- Profile
- Historical
Data
- Earnings
- Ratings
- Holders
Financials
Income Statement
Balance Sheet
Cash Flow Statement
News
- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...
- 13Ds
- 13Fs
- 13Gs
- Analyst Comments
- Analyst EPS Change
- Analyst EPS View
- Analyst PT Change
- Commodities
- Conference Calls
- Contributors
- Corporate News
- Credit Ratings
- Dividends
- Downgrades
- Earnings
- Economic Data
- Equity Offerings
- ETFs
- FDA
- Fed
- Forex
- General News
- Hedge Funds
- Hot Buybacks
- Hot Comments
- Hot Corp. News
- Hot Dividends
- Hot Downgrades
- Hot Earnings
- Hot FDA News
- Hot Guidance
- Hot Hedge Fund News
- Hot Insider Trades
- Hot IPOs
- Hot List
- Hot M&A
- Hot Mgmt Changes
- Hot New Coverage
- Hot Upgrades
- Insiders' Blog
- IPOs
- Life Enjoyed
- Litigation
- Management Comments
- Market Check
- Momentum Movers
- New Coverage
- Option EPS Action
- Options
- Press Releases
- Private Equity
- SEC Filings
- Special Dividends
- Special Reports
- Stock Splits
- Technicals
- Trader Talk
- Trading Halts
- Upgrades
Pharmacyclics, Inc. (NQ:PCYC)
Delayed:
88.26
+1.07 (1.23%)
Trade Now!
Previous Close
$87.19
52 Week High
$95.85
Open
$87.46
52 Week Low
$40.65
Day High
$88.72
P/E
519.18
Day Low
$86.50
EPS
$0.17
Volume
54,080
Friends, Peers and Foes
(?)
:
O
,
ZLTQ
,
AAMRQ
,
ARNA
,
THLD
(more...)
ALERTS
|
RSS
All Recent
SI Reports
Press Releases
SEC Filings
Major News
Jun 18, 2013 05:21 PM
Form 8-K PHARMACYCLICS INC For: Jun 18
Jun 17, 2013 08:50 AM
Form 8-K PHARMACYCLICS INC For: Jun 16
Jun 17, 2013 08:47 AM
Form 8-K PHARMACYCLICS INC For: Jun 16
Jun 16, 2013 06:00 AM
Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
Jun 10, 2013 12:47 PM
Form SC 13G/A PHARMACYCLICS INC Filed by: Capital World Investors
Jun 6, 2013 06:47 PM
Form 4 PHARMACYCLICS INC For: Jun 06 Filed by: Shearer Scott T
Jun 3, 2013 09:01 AM
Form 8-K PHARMACYCLICS INC For: Jun 02
May 31, 2013 08:16 PM
Form 4 PHARMACYCLICS INC For: May 31 Filed by: Hemmi Gregory
May 31, 2013 08:06 PM
Form 4 PHARMACYCLICS INC For: May 31 Filed by: Tan Heow
May 31, 2013 08:04 PM
Form 4 PHARMACYCLICS INC For: May 31 Filed by: Love Richard B
View All Articles
Feb 14, 2013 04:08 PM
Pharmacyclics, Inc. (PCYC) Tops Q2 EPS by 33c
Nov 5, 2012 06:38 AM
Pharmacyclics, Inc. (PCYC) Tops Q1 EPS by 39c
Sep 5, 2012 06:33 AM
Pharmacyclics, Inc. (PCYC) Posts Q4 Loss of 22c/Share
May 10, 2012 06:40 AM
Pharmacyclics, Inc. (PCYC) Posts Narrower than Expected Q1 Loss of 14c/Share
Feb 9, 2012 06:38 AM
Pharmacyclics, Inc. (PCYC) Blows Up Q2 Views, Posts Surprise Profit
Nov 7, 2011 07:08 AM
Pharmacyclics, Inc. (PCYC) Posts Q3 non-GAAP Loss of 18c/Sh
Sep 12, 2011 04:12 PM
Pharmacyclics, Inc. (PCYC) Posts Wider than Expected Q4 Loss
View All Major News
May 13, 2013 06:47 AM
RBC Capital Upgrades Pharmacyclics (PCYC) to Outperform
May 7, 2013 07:43 AM
Goldman Sachs Starts Pharmacyclics (PCYC) at Neutral
Apr 11, 2013 06:32 AM
Pharmacyclics (PCYC) Hits $50M Milestone with RESONATE-2 Enrollment
Apr 8, 2013 01:02 PM
Pharmacyclics (PCYC) Updates on CLL Treatment Ibrutinib Phase II
Apr 8, 2013 09:07 AM
Streetinsider.com Pre-Open Movers 04/08: (LUFK) (BCRX) (PCYC) Higher; (DCTH) (OMPI) (BYI) Lower
Apr 8, 2013 06:31 AM
Pharmacyclics (PCYC) Receives Additional BTD from FDA for Ibrutinib
Mar 20, 2013 10:54 AM
Notable Analyst Rating Changes 03/20: (WAC) (BBRY) (WAG) Upgraded; (YHOO) (ZNGA) (DE) Downgraded
Mar 20, 2013 07:08 AM
Morgan Stanley Starts Pharmacyclics (PCYC) at Equalweight
Mar 8, 2013 08:20 AM
Pharmacyclics (PCYC) Prices 2.2M Stock Offering
Mar 7, 2013 04:40 PM
Pharmacyclics (PCYC) Moves Lower on 2.2M Stock Offering
View All Reports
Jun 16, 2013 06:00 AM
Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
May 1, 2013 04:05 PM
Pharmacyclics Reports First Quarter 2013 Results
Apr 24, 2013 04:05 PM
Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
View All Press Releases
Jun 18, 2013 05:21 PM
Form 8-K PHARMACYCLICS INC For: Jun 18
Jun 17, 2013 08:50 AM
Form 8-K PHARMACYCLICS INC For: Jun 16
Jun 17, 2013 08:47 AM
Form 8-K PHARMACYCLICS INC For: Jun 16
Jun 10, 2013 12:47 PM
Form SC 13G/A PHARMACYCLICS INC Filed by: Capital World Investors
Jun 6, 2013 06:47 PM
Form 4 PHARMACYCLICS INC For: Jun 06 Filed by: Shearer Scott T
Jun 3, 2013 09:01 AM
Form 8-K PHARMACYCLICS INC For: Jun 02
May 31, 2013 08:16 PM
Form 4 PHARMACYCLICS INC For: May 31 Filed by: Hemmi Gregory
May 31, 2013 08:06 PM
Form 4 PHARMACYCLICS INC For: May 31 Filed by: Tan Heow
May 31, 2013 08:04 PM
Form 4 PHARMACYCLICS INC For: May 31 Filed by: Love Richard B
May 31, 2013 08:03 PM
Form 4 PHARMACYCLICS INC For: May 31 Filed by: McGreivy Jesse
View All Filings
Entities mentioned with
PCYC
Earnings
|
View Related Stories »
Needham & Company
|
View Related Stories »
Brean Murray Carret & Co.
|
View Related Stories »
RBC Capital
|
View Related Stories »
Bank of America
|
View Related Stories »
BWS Financial
|
View Related Stories »
Morgan Stanley
|
View Related Stories »
Unusual 11 Mid-Day Movers
|
View Related Stories »
KeyBanc
|
View Related Stories »
Notable Analyst Rating Changes
|
View Related Stories »
Stifel Nicolaus
|
View Related Stories »
Temple-Inland/International Paper
|
View Related Stories »
Dividend
|
View Related Stories »
Jefferies & Co
|
View Related Stories »
Citi
|
View Related Stories »
Merrill Lynch
|
View Related Stories »
Trading Radar
|
View Related Stories »
Morning Movers
|
View Related Stories »
Merriman Curhan Ford
|
View Related Stories »
Roth Capital
|
View Related Stories »
Credit Suisse
|
View Related Stories »
Lazard
|
View Related Stories »
Standard & Poor's
|
View Related Stories »
Longbow Research
|
View Related Stories »
Rodman & Renshaw
|
View Related Stories »
Show More...
View All Entities